Your browser doesn't support javascript.
loading
The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.
Knipe, Rachel S; Tager, Andrew M; Liao, James K.
  • Knipe RS; Pulmonary and Critical Care Unit and Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (R.S.K., A.M.T.); and Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois (J.K.L.).
  • Tager AM; Pulmonary and Critical Care Unit and Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (R.S.K., A.M.T.); and Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois (J.K.L.).
  • Liao JK; Pulmonary and Critical Care Unit and Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (R.S.K., A.M.T.); and Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois (J.K.L.) jliao@medicine.bsd.uchicago.edu.
Pharmacol Rev ; 67(1): 103-17, 2015.
Article en En | MEDLINE | ID: mdl-25395505

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Transducción de Señal / Inhibidores de Proteínas Quinasas / Quinasas Asociadas a rho / Fibrosis Pulmonar Idiopática / Terapia Molecular Dirigida / Pulmón Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Transducción de Señal / Inhibidores de Proteínas Quinasas / Quinasas Asociadas a rho / Fibrosis Pulmonar Idiopática / Terapia Molecular Dirigida / Pulmón Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article